基于共识的复苏性主动脉内球囊阻断适应证:日本联合调查与描述性数据库研究
本研究通过11名创伤专家五轮Delphi调查,从日本创伤数据库42项止血操作中定义REBOA适当适应证为腹腔内、腹膜后、骨盆和四肢出血。JTDB注册的361706例创伤患者中1833例接受REBOA,1077例符合适当适应证、756例不符合。不符合适应证者院内死亡率(72.9% vs 57.6%,p<0.001)和急诊科死亡率(38.6% vs 15.4%,p<0.001)均显著高于符合者。超过40%的REBOA用于适当适应证之外,作者认为需进一步研究止血操作与结局的关联。
要点
- 日本创伤专家Delphi共识定义REBOA适当适应证为:腹腔内出血、腹膜后出血、骨盆出血和四肢出血。
- JTDB中1833例接受REBOA,1077例符合适当适应证,756例不符合。
- 不符合适应证者院内死亡率72.9% vs 符合者57.6%(p<0.001),急诊科死亡率38.6% vs 15.4%(p<0.001)。
- 超过40%的REBOA使用超出了本共识定义的适当适应证。
- 观察死亡率高于预测死亡率,但2013-2019年较2004-2012年更接近预测死亡率。
适用人群与场景
- 日本创伤数据库(JTDB)注册的创伤患者中接受REBOA者。
- 研究基于42项日本创伤数据库定义的止血操作进行Delphi调查。
诊断标准与关键阈值
- 适当适应证(Delphi共识定义):腹腔内出血、腹膜后出血、骨盆出血、四肢出血。
- 不符合上述四项之一者定义为不适当适应证。
研究设计与关键结果
- 研究类型:联合Delphi调查与描述性数据库研究;11名创伤专家参与五轮问卷评估。
- 共识结果:腹腔内、腹膜后、骨盆和四肢出血被定义为REBOA适当适应证。
- JTDB注册361706例创伤患者,1833例接受REBOA:1077例适当适应证,756例不适当适应证。
- 院内粗死亡率:不适当适应证组72.9% vs 适当适应证组57.6%(p<0.001)。
- 急诊科粗死亡率:不适当适应证组38.6% vs 适当适应证组15.4%(p<0.001)。
- 观察死亡率高于预测死亡率,但2013-2019年较2004-2012年更接近预测死亡率。
证据类型、等级与局限
- 证据类型:基于专家共识的联合调查与描述性数据库研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为需进一步研究以阐明相应止血操作与REBOA结局的关联。
- 本共识将REBOA适当适应证限定为腹腔内、腹膜后、骨盆和四肢出血;不符合者死亡率更高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Resuscitative endovascular balloon occlusion of the aorta (REBOA) has been increasingly used in recent years as an adjunctive strategy to haemostatic procedures to counteract exsanguination in patients with trauma. However, no consensus has been reached regarding the haemostatic procedures deemed appropriate indications for REBOA. This study aimed to define appropriate indications for REBOA through consensus among trauma specialists and to investigate the characteristics and outcomes of patients undergoing REBOA with or without appropriate indications defined in this study.
METHODS: Using the 42 haemostatic procedures defined in the Japan Trauma Databank (JTDB), we conducted a repeated Delphi survey to obtain consensus from trauma specialists on the haemostatic procedures deemed appropriate indications for REBOA. Subsequently, patients registered in the JTDB who underwent REBOA were divided into two groups based on whether they had appropriate or inappropriate indications, as defined through the Delphi survey. Patient baseline characteristics, door-to-haemostasis time, door-to-blood transfusion time, emergency-department and in-hospital mortality, and complications were compared between the groups. The observed mortality and predicted mortality were compared.
RESULTS: After five rounds of questionnaire assessments including 11 trauma specialists, intraabdominal, retroperitoneal, pelvic, and extremity haemorrhage were defined as consensus-based appropriate indications for REBOA. Among the 361,706 patients with trauma registered in the JTDB, 1833 underwent REBOA: 1077 with appropriate and 756 with inappropriate indications. Crude in-hospital mortality (57.6 vs. 72.9 %, p < 0.001) and crude emergency-department mortality (15.4 vs. 38.6 %, p < 0.001) were significantly higher in patients with inappropriate indications than in those with appropriate indications. The observed mortality was higher than the predicted mortality, but it more closely aligned with the predicted mortality in 2013-2019 than in 2004-2012.
CONCLUSION: In over 40 % of cases in which REBOA was employed, it was used outside the appropriate indications defined in this study. Mortality was higher among patients with inappropriate indications than in those with appropriate indications. Further studies are required to elucidate the association between corresponding haemostatic procedures and outcomes for REBOA.
参考来源
- Suzuki T, Shiraishi A, Endo A, et al. Consensus-based indications for resuscitative endovascular balloon occlusion of the aorta: a combined survey and descriptive database study in Japan. Injury. 2025. PMID: 40664566. doi:10.1016/j.injury.2025.112589
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。